AP NEWS

Eiger BioPharma: 2Q Earnings Snapshot

August 10, 2018

PALO ALTO, Calif. (AP) _ Eiger BioPharmaceuticals Inc. (EIGR) on Friday reported a loss of $9.9 million in its second quarter.

On a per-share basis, the Palo Alto, California-based company said it had a loss of 82 cents.

The results met Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was also for a loss of 82 cents per share.

Eiger BioPharma shares have decreased 29 percent since the beginning of the year. The stock has climbed 28 percent in the last 12 months.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on EIGR at https://www.zacks.com/ap/EIGR

AP RADIO
Update hourly